Back to search
FDAFDA · Food and drugs·Recall number D-0745-2026

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

Published August 12, 2026 · Recall initiated: August 5, 2026

Summary

FDA records drug Class II recall D-0745-2026, published August 12, 2026 and initiated August 5, 2026. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Lot: Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

What to do

Voluntary: Firm initiated · Letter

Get an email if MIRABEGRON has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MIRABEGRON
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Nationwide in the USA
Lot
Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3. recalled?

Yes. FDA published recall D-0745-2026 on August 12, 2026. Reported hazard: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MIRABEGRON.